Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

March 31, 2001

Primary Completion Date

September 30, 2003

Study Completion Date

September 30, 2003

Conditions
Thyroid Cancer
Interventions
DRUG

Euthyroid Group

Euthyroid Group: Received rhTSH to prepare for radioiodine therapy.

Trial Locations (3)

21287

Johns Hopkins Division of Endocrinology & Metabolism, Baltimore

77030

M.D. Anderson Cancer Center, Houston

Unknown

Institute Gustave Roussy, Paris

All Listed Sponsors
collaborator

Gustave Roussy, Cancer Campus, Grand Paris

OTHER

collaborator

M.D. Anderson Cancer Center

OTHER

collaborator

Genzyme, a Sanofi Company

INDUSTRY

lead

Johns Hopkins University

OTHER

NCT00181168 - Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer | Biotech Hunter | Biotech Hunter